The short answer: Does NyQuil contain an antihistamine?
Yes, the US Vicks NyQuil Cold & Flu LiquiCaps contain doxylamine succinate, which the Drug Facts label identifies as an antihistamine. Each LiquiCap contains 6.25 mg of doxylamine succinate alongside acetaminophen and dextromethorphan, the other two active ingredients in that particular formula.
That answer applies to the specific Cold & Flu LiquiCap product. NyQuil is a product family, not a single medicine, and formulations differ. The separately marketed NyQuil Allergy liquid lists doxylamine succinate as its sole active ingredient and markets it for runny nose, sneezing, itchy or watery eyes, and itchy throat. Other NyQuil products may contain different active ingredients, different strengths, or no antihistamine at all. Checking the active-ingredient panel on the exact package you are considering is the only reliable way to know what that particular formula contains.
Which antihistamine is in NyQuil and what does it do?
The antihistamine in the cited NyQuil Cold & Flu LiquiCaps is doxylamine succinate. Within that multi-symptom formula, the label assigns doxylamine the role of providing temporary relief of runny nose and sneezing associated with the common cold or flu.
The product combines three active ingredients, each serving a different labeled purpose. Acetaminophen functions as a pain reliever and fever reducer, addressing sore throat, headache, minor aches and pains, and fever. Dextromethorphan HBr acts as a cough suppressant. Only doxylamine carries the antihistamine designation on the label. Recognizing which ingredient does what matters when comparing products or checking for duplicate active ingredients across different medicines.
NyQuil Cold & Flu is intended for temporary symptom relief. It does not treat the underlying viral infection or shorten the duration of a cold or flu.
NyQuil Ingredients and Usage: Quick Check
NyQuil products do not all have the same ingredients
The name NyQuil appears on multiple products with different active ingredients, strengths, and intended uses. The Cold & Flu LiquiCap formula documented here combines acetaminophen 325 mg, dextromethorphan HBr 15 mg, and doxylamine succinate 6.25 mg per capsule. NyQuil Allergy liquid, by contrast, lists doxylamine succinate 6.25 mg per 15 mL as its active ingredient and is marketed for allergy symptoms rather than cold and flu relief. Other versions may carry names such as Severe, include additional active ingredients, or come in liquid form with different concentrations.
The Drug Facts label on each package documents what that specific product contains, how much to take, and who should not use it. Directions, warnings, and age restrictions documented for one formula must not be transferred to another. The cited Cold & Flu label explicitly instructs consumers who use other DayQuil or NyQuil products to read each label carefully to ensure correct dosing. Switching between liquid and capsule forms, or between Cold & Flu and Allergy formulations, without checking the new label creates unnecessary risk.
Why the antihistamine can make you drowsy
The cited NyQuil Cold & Flu label warns that marked drowsiness may occur and advises caution when driving or operating machinery. That drowsiness is a medication effect linked to the presence of doxylamine, a sedating antihistamine. Many people use NyQuil at night because the drowsiness aligns with their intention to rest, but the timing choice does not eliminate the need to follow the label precautions.
Drowsiness from an antihistamine is not the same as treating insomnia. NyQuil Cold & Flu is a multi-symptom cold and flu medicine, not a sleep aid, and the label explicitly says not to use the product to make a child sleep. Using it solely for sedation when cold or flu symptoms are absent exposes the person to unnecessary acetaminophen and dextromethorphan.
The label warns against consuming alcoholic drinks while using the product and notes that alcohol, sedatives, and tranquilizers may increase drowsiness. Combining NyQuil with these substances intensifies sedation and raises the risk of accidents, respiratory depression, and impaired judgment.
Important warnings and medication-combination risks
Because the cited NyQuil Cold & Flu product contains acetaminophen, the label says not to use it with any other drug containing acetaminophen, whether prescription or nonprescription. Many pain relievers, fever reducers, and combination cold medicines list acetaminophen as an active ingredient, often under abbreviated names such as APAP or acetamin. Taking more than one acetaminophen-containing product at the same time can lead to unintentional overdose. The label warns of severe liver damage if more than four doses are taken in 24 hours, if the product is combined with other acetaminophen-containing drugs, or if three or more alcoholic drinks are consumed daily while using it. In the event of overdose, the label directs the user to obtain medical help or contact a Poison Control Center immediately, even if no symptoms are apparent.
The label prohibits using NyQuil Cold & Flu while taking a prescription monoamine oxidase inhibitor or for two weeks after stopping one. It advises asking a doctor or pharmacist before use with sedatives, tranquilizers, or warfarin. Enhanced drowsiness from combining sedating medications and the risk of bleeding changes with warfarin make these interactions clinically significant.
People with liver disease, glaucoma, certain chronic cough or breathing problems, excessive-phlegm cough, or trouble urinating due to an enlarged prostate should ask a doctor before use. The label also advises consulting a health professional before use during pregnancy or breastfeeding.
When to ask a healthcare professional for advice
Anyone uncertain whether NyQuil interacts with a current medication or whether their medical history makes use inadvisable should consult a doctor or pharmacist before taking the product. The label lists specific conditions and medications that warrant pre-use consultation, and those should be taken seriously rather than dismissed as routine cautions.
The label provides clear escalation triggers. Stop use and ask a doctor if pain or cough worsens or lasts more than seven days, fever worsens or lasts more than three days, redness or swelling is present, new symptoms occur, or cough returns or occurs with a rash or persistent headache. These may signal a condition that requires a different treatment approach or medical evaluation.
Suspected overdose is a medical emergency. The label directs anyone who has taken more than the recommended dose to obtain medical help or contact a Poison Control Center immediately, even in the absence of symptoms. Acetaminophen overdose can cause delayed liver injury that may not be apparent for hours or days, and early intervention improves outcomes. This is distinct from routine symptom monitoring and requires urgent professional response.
NyQuil is a brand with multiple formulations; the US Vicks NyQuil Cold & Flu LiquiCaps contain doxylamine succinate (6.25 mg) as an antihistamine, together with acetaminophen and dextromethorphan. Other NyQuil products may have different ingredients, and some may lack an antihistamine entirely, so the label must be checked.
Doxylamine causes drowsiness; the label warns against driving, using alcohol or other sedatives, and against using the product solely for sedation. Because it also contains acetaminophen, combining with other acetaminophen-containing drugs or alcohol can cause liver damage, and MAOI interactions are prohibited.
Users should consult a healthcare professional if they have liver disease, glaucoma, prostate issues, are pregnant or breastfeeding, or take warfarin, sedatives, tranquilizers, etc., and stop use if symptoms persist beyond recommended durations or if overdose is suspected.
Published by: Vicks
Published by: MedlinePlus, U.S. National Library of Medicine
Published by: U.S. Food and Drug Administration
Questions and feedback
Please leave out passwords, medical record numbers, insurance details, financial information, exact addresses, and any other confidential or directly identifying details from your message.
